EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inducing programmed cell death trough MazEF system to combat Staphylococcus aureus: A non-antibiotic treatment candidate

Shahriar Bakhti, Mohammad Hossein Ahmadi iD, Parviz Owlia

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0314867 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Shahriar Bakhti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran. Hauptthemen laut MEDLINE: Microbial Sensitivity Tests, Staphylococcus aureus, Escherichia coli, Methicillin-Resistant Staphylococcus aureus. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iran National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of the present study was to evaluate the role of extracellular death factor (EDF) derived from Escherichia coli in the induction of programmed cell death (PCD) in methicillin-resistant and -susceptible Staphylococcus aureus (MRSA and MSSA). The confirmation of bacterial strains as well as the minimum inhibitory concentration (MIC) test were performed according to CLSI, 2022. The extraction and efficacy determination of EDF as well as the CFU assessment were done. The expression of mazE and mazF gens in different conditions was evaluated by Real-time PCR. The likely formation of persister cells from MRSA and MSSA, and the possible synthesis of EDF in old cultures of these pathogens was evaluated, as well. The combination of EDF of two E . coli strains and sub-MIC rifampin reduced the CFUs of MRSA and MSSA strains in mid-logarithmic growth phase while increased the expression of mazF several times more than mazE gene. The expression of these genes in different conditions were unlike. EDF was produced in the old cultures of MRSA and MSSA. The supernatant of E . coli 25922 was more powerful than the clinical strain ones to decrease the CFUs of the MRSA and MSSA. The EDF derived from E . coli in combination with sub-MIC rifampin could induce PCD in MRSA and MSSA through activation of the MazEF system. This phenomenon could be exploited as a non-antibiotic treatment candidate to combat the infections caused by the antibiotic-resistant pathogens. However, more studies should be performed in this regard.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Microbial Sensitivity TestsStaphylococcus aureusEscherichia coliMethicillin-Resistant Staphylococcus aureusApoptosisEscherichia coli ProteinsAnti-Bacterial AgentsStaphylococcal InfectionsRifampinGene Expression Regulation, BacterialHumansDNA-Binding ProteinsEndoribonucleases

Substanzen

Escherichia coli ProteinsAnti-Bacterial AgentsMazF protein, E coliMazE protein, E coliRifampinDNA-Binding ProteinsEndoribonucleases

Autor:innen und Institutionen

  • Department of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran.

ORCID-Profile: Mohammad Hossein Ahmadi

Förderung

  • Iran National Science Foundation

Zitieren

APA

Bakhti, S., Ahmadi, M. H., & Owlia, P. (2024). Inducing programmed cell death trough MazEF system to combat Staphylococcus aureus: A non-antibiotic treatment candidate. PLOS ONE. https://doi.org/10.1371/journal.pone.0314867

Vancouver

Bakhti S, Ahmadi MH, Owlia P. Inducing programmed cell death trough MazEF system to combat Staphylococcus aureus: A non-antibiotic treatment candidate. PLOS ONE. 2024. doi:10.1371/journal.pone.0314867

BibTeX
@article{Bakhti2024,
  author = {Bakhti, Shahriar and Ahmadi, Mohammad Hossein and Owlia, Parviz},
  title = {Inducing programmed cell death trough MazEF system to combat Staphylococcus aureus: A non-antibiotic treatment candidate},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0314867}
}
Kostenlos starten →